TORCHLIGHT, NCT04085276: Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment |
|
|
| Active, not recruiting | 3 | 531 | RoW | JS001, Nab-Paclitaxel, Placebo | Shanghai Junshi Bioscience Co., Ltd. | Triple-Negative Breast Cancer | 12/24 | 12/25 | | |
NCT04990063: Adoptive TKC Transfer Combined With Chemotherapy for Advanced Non-small Cell Lung Cancer (NSCLC) |
|
|
| Recruiting | 1 | 20 | RoW | Chemotherapy, Adoptive TKC transfer therapy | suhaichuan, Shanghai Biomed-union Biotechnology Co., Ltd. | Advanced Non-small Cell Lung Cancer, Chemotherapy | 08/22 | 11/23 | | |
